Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2007; 13(7): 1098-1102
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1098
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1098
Table 3 Correlation between tumor location and CD117 expression in patients with GISTs
| Tumor location | CD117 expression | |||
| Negative | Positive | Total | ||
| Esophagus | 1 | 2 | 3 | |
| 33.30% | 66.70% | 100% | ||
| Stomach | 8 | 11 | 19 | |
| 42.10% | 57.90% | 100% | ||
| Small intestine | 5 | 18 | 23 | |
| 21.70% | 78.30% | 100% | ||
| Large intestine | 1 | 4 | 5 | |
| 20% | 80% | 100% | ||
| Total | 15 | 35 | 50 | |
| 30% | 70% | 100% | ||
- Citation: Kontogianni-Katsarou K, Lariou C, Tsompanaki E, Vourlakou C, Kairi-Vassilatou E, Mastoris C, Pantazi G, Kondi-Pafiti A. KIT-negative gastrointestinal stromal tumors with a long term follow-up: A new subgroup does exist. World J Gastroenterol 2007; 13(7): 1098-1102
- URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1098.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1098